These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15754671)

  • 21. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. QTc changes after 6 months of second-generation antipsychotic treatment in children and adolescents.
    de Castro MJ; Fraguas D; Laita P; Moreno D; Parellada M; Pascual D; Alvarez M; Merchán-Naranjo J; Rapado M; Giráldez M; Leiva M; Arango C
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):381-3. PubMed ID: 18759648
    [No Abstract]   [Full Text] [Related]  

  • 23. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
    Potkin SG; Gharabawi GM; Greenspan AJ; Mahmoud R; Kosik-Gonzalez C; Rupnow MF; Bossie CA; Davidson M; Burtea V; Zhu Y; Trivedi JK
    Schizophr Res; 2006 Jul; 85(1-3):254-65. PubMed ID: 16797162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
    Byerly MJ; Nakonezny PA; Bettcher BM; Carmody T; Fisher R; Rush AJ
    Schizophr Res; 2006 Sep; 86(1-3):244-50. PubMed ID: 16730951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lessons to be learned from CATIE and CUtLASS.
    Sutton BJ
    Psychiatr Serv; 2008 May; 59(5):473. PubMed ID: 18450999
    [No Abstract]   [Full Text] [Related]  

  • 27. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
    Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Capuano GA; Rosenheck RA; Keefe RS; Miller AL; Belz I; Hsiao JK;
    Am J Psychiatry; 2007 Mar; 164(3):415-27. PubMed ID: 17329466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial.
    Lublin H; Haug HJ; Koponen H; Sigmundsson T; Kolb SA
    World J Biol Psychiatry; 2009; 10(4 Pt 3):710-8. PubMed ID: 18803070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
    Sacchetti E; Valsecchi P; Parrinello G;
    Schizophr Res; 2008 Jan; 98(1-3):55-65. PubMed ID: 17933497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study.
    Chatterjee S; Chen H; Johnson ML; Aparasu RR
    Am J Geriatr Pharmacother; 2012 Apr; 10(2):83-94. PubMed ID: 22306198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes associated with atypical antipsychotic treatment may be severe but reversible: case report.
    Dibben CR; Kalavalapalli SS; Linnington HE; Hynes FA; Dinneen SF; Adler AI; McKenna PJ
    Int J Psychiatry Med; 2005; 35(3):307-11. PubMed ID: 16480245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second-generation antipsychotics cause weight gain in youths.
    Harv Ment Health Lett; 2010 Jan; 26(7):7. PubMed ID: 20217902
    [No Abstract]   [Full Text] [Related]  

  • 33. Care maps: atypical antipsychotics. Introduction.
    Houltram B; Scanlan M
    Nurs Stand; 2004 May 19-25; 18(36):42-4. PubMed ID: 15176111
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
    Layton D; Harris S; Wilton LV; Shakir SA
    J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of atypical antipsychotics in the treatment of schizophrenia.
    Jessen LM
    Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
    [No Abstract]   [Full Text] [Related]  

  • 36. Parkinsonism and akathisia with quetiapine: three case reports.
    Bharadwaj R; Grover S
    J Clin Psychiatry; 2008 Jul; 69(7):1189-91. PubMed ID: 18687022
    [No Abstract]   [Full Text] [Related]  

  • 37. Atypical antipsychotics for the treatment of disruptive behavior.
    Lohr WD; Honaker J
    Pediatr Ann; 2013 Feb; 42(2):72-7. PubMed ID: 23379410
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover study.
    Shin JY; Choi NK; Jung SY; Lee J; Kwon JS; Park BJ
    J Psychopharmacol; 2013 Jul; 27(7):638-44. PubMed ID: 23535349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety in treating bipolar disorder.
    Gupta S
    J Fam Pract; 2003 Mar; Suppl():S26-9. PubMed ID: 12676082
    [No Abstract]   [Full Text] [Related]  

  • 40. Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidone.
    Beelen AP; Yeo KT; Lewis LD
    Hum Exp Toxicol; 2001 Apr; 20(4):215-9. PubMed ID: 11393275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.